- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Caravan Health’s Tim Gronniger on Boosting ACO Participation
On this episode of Managed Care Cast, we speak with Tim Gronniger, the CEO of Caravan Health, about what to look for as accountable care organizations (ACOs) and policy makers try to encourage more providers to join value-based care arrangements.
The “muscles” that were created in value-based care programs in the years before the pandemic have been helpful to accountable care organizations (ACOs) in dealing with the turmoil in health care delivery, according to our guest on this week’s Managed Care Cast.
Tim Gronniger, MPP, MHSA, the CEO of Caravan Health, discusses what may come next (or ideally might come next) as ACOs move forward as the United States adjusts to an endemic phase of COVID-19. We discuss financing and policy and what is needed to achieve CMS’ goal of furthering the shift to ACOs by 2030.
Gronniger, former chief of staff and director of Delivery System Reform at CMS in the Obama administration, also discusses the company’s recent acquisition by Signify Health.
Listen above or through one of these podcast services:
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD
January 28th 2025The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes (T2D) and chronic kidney disease (CKD), addressing their cardiovascular (CV) and kidney disease risks.
Read More
